Poly Medicure Ltd

Poly Medicure Ltd

Poly Medicure Ltd announced the allotment of 1,975 equity shares under its Employee Stock Option Scheme, 2020, and the re-appointment of M/s Jai Prakash & Company as the Cost Auditors for the Financial Year 2026-27. The company also reported unaudited financial results for the first quarter ended June 30, 2026.

Poly Medicure Ltd

Poly Medicure Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company's total income for the quarter was ₹55,878.45 crore, with a net income of ₹45,974.91 crore. The company has also announced the re-appointment of its cost auditors, M/s Jai Prakash & Company, for the financial year 2026-27. Additionally, the company has informed the resignation of its Deputy Company Secretary, Mr. Ravi Prakash, and the grant of stock options to its employees.

Poly Medicure Ltd

Poly Medicure Ltd announced its unaudited financial results for the first quarter ended June 30, 2026, with a standalone income of ₹43,109.95 and a consolidated income of ₹52,537.55. The company also approved the grant of stock options to eligible employees and the allotment of equity shares to employees who exercised their options under the Employee Stock Option Scheme, 2020. Additionally, the company re-appointed M/s Jai Prakash & Company as the Cost Auditors for the financial year 2026-27 and announced the resignation of Mr. Ravi Prakash as Deputy Company Secretary and Compliance Officer.

Poly Medicure Ltd

Poly Medicure Ltd's board meeting outcome for the quarter ended June 30, 2026, includes unaudited financial results, grant of stock options, allotment of stock options, re-appointment of cost auditors, and resignation of deputy company secretary.

Poly Medicure Ltd

Poly Medicure Ltd has announced an earnings call to discuss its unaudited financial results for the first quarter ended June 30, 2026.

Poly Medicure Ltd

Poly Medicure Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 to consider and approve the Unaudited Financial Results (Consolidated & Standalone) of the company for the First Quarter ended on 30 June, 2026.

Poly Medicure Ltd

Poly Medicure Ltd has announced the rescheduling of its one-on-one/virtual investor/analyst meet. The meeting, originally scheduled for Tuesday, June 23, 2026, at 12:00 PM, has been moved to Wednesday, June 24, 2026, at 11:00 AM. The venue and format of the meeting will remain the same. The company explicitly stated that no Unpublished Price Sensitive Information will be shared during the meet.

Poly Medicure Ltd

Poly Medicure Ltd has informed about a scheduled one-on-one meeting with Nuvama, an analyst/investor, on June 25, 2026. The meeting will take place at the company's plant in Faridabad. This intimation is in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has explicitly stated that no Unpublished Price Sensitive Information will be shared during this interaction.